The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).
 
Daniel G. Stover
Consulting or Advisory Role - Novartis
Research Funding - NeoGenomics Laboratories (Inst)
 
Roberto Salgado
Consulting or Advisory Role - AstraZeneca; BMS; Roche
Speakers' Bureau - Exact Sciences
Research Funding - Merck; Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Merck; Roche
 
Oleksandr Savenkov
No Relationships to Disclose
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Mylan; Sanofi
 
Mark Jesus Mendoza Magbanua
No Relationships to Disclose
 
Sherene Loi
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Lilly (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Tallac Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - Roche Medical writing support
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Diaccurate; Gilead Sciences; Lilly; Novartis
 
Mark Vater
No Relationships to Disclose
 
Kristyn Glover
No Relationships to Disclose
 
Mark A Watson
No Relationships to Disclose
 
Yujia Wen
No Relationships to Disclose
 
W. Fraser Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Merck
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Charles Perou
Stock and Other Ownership Interests - NanoString Technologies; Reveal Genomics
 
Lisa A. Carey
Research Funding - AstraZeneca (Inst); NanoString Technologies (Inst); Seagen (Inst); Veracyte (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly; Novartis (Inst); SeaGen
 
Ann H. Partridge
Patents, Royalties, Other Intellectual Property - I receive small royalty payments for co-authoring the breast cancer survivorship section of UpToDate
 
Hope S. Rugo
Consulting or Advisory Role - Blueprint Medicines; Napo Pharmaceuticals; Puma Biotechnology; Scorpion Therapeutics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Pionyr (Inst); Sermonix Pharmaceuticals (Inst); Taiho Oncology (Inst); Veru (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Merck